MIAT and in situ carcinoma: Concerning the subgroup MIAT rs2331291, neither the genotypic nor allelic frequencies (p = 0.25, p = 0.823, and p = 0.511, p = 0.195, respectively) between the diabetic and non-diabetic hypertensive CIS cases nor between the diabetic and non-diabetic non-hypertensive CIS cases demonstrate any statistically significant differences (Supplementary Table S3).